Contrast ultrasound molecular imaging of inflammation in cardiovascular disease

Jonathan R. Lindner

Research output: Contribution to journalReview articlepeer-review

60 Scopus citations


The cellular immune response plays an important role in almost every major form of cardiovascular disease. The ability to image the key aspects of the immune response in the clinical setting could be used to improve diagnostic information, to provide important prognostic or risk information, and to customize therapy according to disease phenotype. Accordingly, targeted imaging probes for assessing inflammation have been developed for essentially all forms of medical imaging. Molecular imaging of inflammation with contrast ultrasound relies on the detection of targeted microbubble or other gas-filled particle contrast agents. These agents are confined to the vascular space and, hence, have been targeted to either activated leucocytes or endothelial cell adhesion molecules that are upregulated in inflammation and mediate leucocyte recruitment and adhesion. This review focuses on the inflammation-targeting strategies for ultrasound contrast agents and how they have been matched to cardiovascular disease states such as myocardial ischaemia, infarction, atherosclerosis, transplant rejection, and arteriogenesis.

Original languageEnglish (US)
Pages (from-to)182-189
Number of pages8
JournalCardiovascular research
Issue number2
StatePublished - Nov 2009
Externally publishedYes


  • Contrast ultrasound
  • Inflammation
  • Molecular imaging
  • Myocardial contrast echocardiography

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Contrast ultrasound molecular imaging of inflammation in cardiovascular disease'. Together they form a unique fingerprint.

Cite this